Esperer Onco Nutrition Profile
Key Indicators
- Authorised Capital ₹ 3.37 Cr
as on 13-12-2024
- Paid Up Capital ₹ 3.35 Cr
as on 13-12-2024
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
as on 13-12-2024
- Revenue 360.11%
(FY 2022)
- Profit -13.41%
(FY 2022)
- Ebitda -82.95%
(FY 2022)
- Net Worth 80.91%
(FY 2022)
- Total Assets 144.90%
(FY 2022)
About Esperer Onco Nutrition
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.37 Cr and a paid-up capital of Rs 3.35 Cr.
The company currently has active open charges totaling ₹1.00 Cr.
The Key Managerial Personnel (KMP) at Esperer Onco Nutrition Private Limited India is Raktim Chattopadhyay as CEO. Raktim Chattopadhyay, Sohilkumar Tandel, and Sudipta Chattopadhyay serve as directors at the Company.
- CIN/LLPIN
U24299MH2019PTC322571
- Company No.
322571
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationNavi Mumbai, Maharashtra
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Esperer Onco Nutrition?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raktim Chattopadhyay | CEO | 03-Apr-2020 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raktim Chattopadhyay  | Director | 14-Mar-2019 | Current |
| Sohilkumar Tandel | Director | 08-Aug-2024 | Current |
| Sudipta Chattopadhyay | Director | 20-Dec-2023 | Current |
Financial Performance and Corporate Structure Insights of Esperer Onco Nutrition.
Esperer Onco Nutrition Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 360.11% increase. The company also saw a substantial fall in profitability, with a 13.41% decrease in profit. The company's net worth Soared by an impressive increase of 80.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Esperer Onco Nutrition?
In 2023, Esperer Onco Nutrition had a promoter holding of 99.01% and a public holding of 0.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Esperer Bio-Research Private LimitedActive 6 years 4 monthsRaktim Chattopadhyay, Sohilkumar Tandel and 1 more are mutual person
Health Voitho Technologies Private LimitedActive 5 years 8 monthsRaktim Chattopadhyay and Sudipta Chattopadhyay are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Jul 2021 | ₹1.00 Cr | Open |
How Many Employees Work at Esperer Onco Nutrition?
Esperer Onco Nutrition has a workforce of 18 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Esperer Onco Nutrition, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Esperer Onco Nutrition's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
